These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8797176)

  • 21. Time-course effects of St John's wort on the pharmacokinetics of cyclosporine in dogs: interactions between herbal extracts and drugs.
    Fukunaga K; Orito K
    J Vet Pharmacol Ther; 2012 Oct; 35(5):446-51. PubMed ID: 22091645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective cross-over study comparing the pharmacokinetics of cyclosporine A and its metabolites after oral versus short-time intravenous cyclosporine A administration in pre-heart transplant patients.
    Lehle K; Kirchner GI; Rupprecht L; Gruber M; Birnbaum DE; Schmid FX; Preuner JG
    Transplant Proc; 2007 Dec; 39(10):3323-8. PubMed ID: 18089380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased oral absorption of cyclosporine A after liver ischemia-reperfusion injury in rats: the contribution of CYP3A and P-glycoprotein to the first-pass metabolism in intestinal epithelial cells.
    Ikemura K; Urano K; Matsuda H; Mizutani H; Iwamoto T; Okuda M
    J Pharmacol Exp Ther; 2009 Jan; 328(1):249-55. PubMed ID: 18842703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of diltiazem on the pharmacokinetics of microemulsion cyclosporine A in renal transplantation.
    Bunnag S; Vareesangthip K; Ong-ajyooth L
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S228-34. PubMed ID: 17044476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of multiple oral dosing of itraconazole on the pharmacokinetics of cyclosporine in cats.
    Katayama M; Katayama R; Kamishina H
    J Feline Med Surg; 2010 Jun; 12(6):512-4. PubMed ID: 20371199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In situ and in vivo efficacy of peroral absorption enhancers in rats and correlation to in vitro mechanistic studies.
    Sharma P; Varma MV; Chawla HP; Panchagnula R
    Farmaco; 2005; 60(11-12):874-83. PubMed ID: 16243320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Understanding drug disposition alterations induced by acute spinal cord injury: role of injury level and route of administration for agents submitted to extensive liver metabolism.
    Cruz-Antonio L; Flores-Murrieta FJ; García-Löpez P; Guízar-Sahagún G; Castañeda-Hernández G
    J Neurotrauma; 2006 Jan; 23(1):75-85. PubMed ID: 16430374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decrease in oral bioavailability of ciclosporin by intravenous pulse of methylprednisolone succinate in rats.
    Konishi H; Sumi M; Shibata N; Takada K; Minouchi T; Yamaji A
    J Pharm Pharmacol; 2004 Oct; 56(10):1259-66. PubMed ID: 15482640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contrasting effects of cord injury on intravenous and oral pharmacokinetics of diclofenac: a drug with intermediate hepatic extraction.
    Cruz-Antonio L; Arauz J; Franco-Bourland RE; Guízar-Sahagún G; Castañeda-Hernández G
    Spinal Cord; 2012 Aug; 50(8):632-5. PubMed ID: 22410846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of cyclosporine with phenobarbital in cats: a preliminary study.
    Hoshino Y; Inden T; Otaka R; Fukui D; Satoh H; Katayama M
    J Vet Med Sci; 2019 Nov; 81(11):1621-1623. PubMed ID: 31597813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors that affect absorption behavior of cyclosporin a in gentamicin-induced acute renal failure in rats.
    Shibata N; Morimoto J; Hoshino N; Minouchi T; Yamaji A
    Ren Fail; 2000 Mar; 22(2):181-94. PubMed ID: 10803762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of glycerol-induced acute renal failure on the pharmacokinetics of cyclosporin in rats.
    Shibata N; Ohmae T; Hoshino N; Minouchi T; Yamaji A
    J Pharm Pharmacol; 1999 Apr; 51(4):397-404. PubMed ID: 10385211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclosporin A pharmacokinetics and efficacy in the treatment of atopic dermatitis in dogs.
    Steffan J; Strehlau G; Maurer M; Rohlfs A
    J Vet Pharmacol Ther; 2004 Aug; 27(4):231-8. PubMed ID: 15305852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Marked decrease of cyclosporin bioavailability caused by coadministration of ginkgo and onion in rats.
    Yang CY; Chao PD; Hou YC; Tsai SY; Wen KC; Hsiu SL
    Food Chem Toxicol; 2006 Sep; 44(9):1572-8. PubMed ID: 16762474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclosporin-A enhances non-functional axonal growing after complete spinal cord transection.
    Ibarra A; Hernández E; Lomeli J; Pineda D; Buenrostro M; Martiñón S; Garcia E; Flores N; Guizar-Sahagun G; Correa D; Madrazo I
    Brain Res; 2007 May; 1149():200-9. PubMed ID: 17382306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Achieving adequate cyclosporine exposure in liver transplant recipients: a novel strategy for monitoring and dosing using intravenous therapy.
    Lück R; Böger J; Kuse E; Klempnauer J; Nashan B
    Liver Transpl; 2004 May; 10(5):686-91. PubMed ID: 15108262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclosporine a immunosuppression in sheep with response enhancement by concomitant ketoconazole.
    O'Donoghue HL; Penhale WJ; Manning LS; Reynoldson JA; Turner JH
    Clin Exp Pharmacol Physiol; 1996 Sep; 23(9):797-803. PubMed ID: 8911716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Grapefruit juice effects on the bioavailability of cyclosporin-A in rats.
    Mangano NG; Cutuli VM; Caruso A; De Bernardis E; Amico-Roxas M
    Eur Rev Med Pharmacol Sci; 2001; 5(1):1-6. PubMed ID: 11860217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioavailability assessment of cyclosporine in the rat. Influence of route of administration.
    Luke DR; Brunner LJ; Vadiei K
    Drug Metab Dispos; 1990; 18(2):158-62. PubMed ID: 1971566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic drug monitoring of cyclosporine Neoral in de novo Chinese cardiac transplant recipients treated with an everolimus-cyclosporine immunosuppressive regimen.
    Wang CH; Chou NK; Wu FL; Ko WJ; Tsao CI; Chi NH; Hsu RB; Wang SS
    Transplant Proc; 2006 Sep; 38(7):2132-4. PubMed ID: 16980022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.